<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09250000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P25090</UniProt_ID>
  <Seq_Length>351</Seq_Length>
  <Molecule_Weight>38964</Molecule_Weight>
  <KEGG_ID>hsa:2358</KEGG_ID>
  <Orthology_ID>K04173</Orthology_ID>
  <Function_Summary>Low affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophils chemotactic factors. Binding of FMLP to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The activation of LXA4R could result in an anti-inflammatory outcome counteracting the actions of proinflammatory signals such as LTB4 (leukotriene B4).</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>HM63</Alias>
      <Alias>FMLP-related receptor I</Alias>
      <Alias>FMLP-R-I</Alias>
      <Alias>Lipoxin A4 receptor</Alias>
      <Alias>Formyl peptide receptor-like 1</Alias>
      <Alias>LXA4 receptor</Alias>
      <Alias>RFP</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an N-formyl peptide to initiate a change in cell activity.</Detail>
      <Keyword>N-formyl peptide receptor activity</Keyword>
      <Ontology_ID>GO:0004982</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.</Detail>
      <Keyword>Cell adhesion</Keyword>
      <Ontology_ID>GO:0007155</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed, self-propelled movement of a cellular component without the involvement of an external agent such as a transporter or a pore.</Detail>
      <Keyword>Cellular component movement</Keyword>
      <Ontology_ID>GO:0006928</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).</Detail>
      <Keyword>Chemotaxis</Keyword>
      <Ontology_ID>GO:0006935</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIALDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNFASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPLRVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPMLYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM</Protein_Seq>
    <DNA_Seq>GAAGCACACAGGAAAAGGAGCTTAGCTGCTGGTGCTGCTGGCAAGATGGAAACCAACTTCTCCACTCCTCTGAATGAATATGAAGAAGTGTCCTATGAGTCTGCTGGCTACACTGTTCTGCGGATCCTCCCATTGGTGGTGCTTGGGGTCACCTTTGTCCTCGGGGTCCTGGGCAATGGGCTTGTGATCTGGGTGGCTGGATTCCGGATGACACGCACAGTCACCACCATCTGTTACCTGAACCTGGCCCTGGCTGACTTTTCTTTCACGGCCACATTACCATTCCTCATTGTCTCCATGGCCATGGGAGAAAAATGGCCTTTTGGCTGGTTCCTGTGTAAGTTAATTCACATCGTGGTGGACATCAACCTCTTTGGAAGTGTCTTCTTGATTGGTTTCATTGCACTGGACCGCTGCATTTGTGTCCTGCATCCAGTCTGGGCCCAGAACCACCGCACTGTGAGTCTGGCCATGAAGGTGATCGTCGGACCTTGGATTCTTGCTCTAGTCCTTACCTTGCCAGTTTTCCTCTTTTTGACTACAGTAACTATTCCAAATGGGGACACATACTGTACTTTCAACTTTGCATCCTGGGGTGGCACCCCTGAGGAGAGGCTGAAGGTGGCCATTACCATGCTGACAGCCAGAGGGATTATCCGGTTTGTCATTGGCTTTAGCTTGCCGATGTCCATTGTTGCCATCTGCTATGGGCTCATTGCAGCCAAGATCCACAAAAAGGGCATGATTAAATCCAGCCGTCCCTTACGGGTCCTCACTGCTGTGGTGGCTTCTTTCTTCATCTGTTGGTTTCCCTTTCAACTGGTTGCCCTTCTGGGCACCGTCTGGCTCAAAGAGATGTTGTTCTATGGCAAGTACAAAATCATTGACATCCTGGTTAACCCAACGAGCTCCCTGGCCTTCTTCAACAGCTGCCTCAACCCCATGCTTTACGTCTTTGTGGGCCAAGACTTCCGAGAGAGACTGATCCACTCCCTGCCCACCAGTCTGGAGAGGGCCCTGTCTGAGGACTCAGCCCCAACTAATGACACGGCTGCCAATTCTGCTTCACCTCCTGCAGAGACTGAGTTACAGGCAATGTGAGGATGGGGTCAGGGATATTTTGAGTTCTGTTCATCCTACCCTAATGCCAGTTCCAGCTTCATCTACCCTTGAGTCATATTGAGGCATTCAAGGATGCACAGCTCAAGTATTTATTCAGGAAAAATGCTTTTGTGTCCCTGATTTGGGGCTAAGAAATAGACAGTCAGGCTACTAAAATATTAGTGTTATTTTTTGTTTTTTGACTTCTGCCTATACCCTGGGGTAAGTGGAGTTGGGAAATACAAGAAGAGAAAGACCAGTGGGGATTTGTAAGACTTAGATGAGATAGCGCATAATAAGGGGAAGACTTTAAAGTATAAAGTAAAATGTTTGCTGTAGGTTTTTTATAGCTATTAAAAAAAATCAGATTATGGAAGTTTTCTTCTATTTTTAGTTTGCTAAGAGTTTTCTGTTTCTTTTTCTTACATCATGAGTGGACTTTGCATTTTATCAAATGCATTTTCTACATGTATTAAGATGGTCATATTATTCTTCTTCTTTTATGTAAATCATTATAAATAATGTTCATTAAGTTCTGAATGTTAAACTACTCTTGAATTCCTGGAATAAACCACACTTAGTCCTGATGTACTTTAAATATTTATATCTCACAGGAGTTGGTTAGAATTTCTGTGTTTATGTTTATATACTGTTATTTCACTTTTTCTACTATCCTTGCTAAGTTTTCATAGAAAATAAGGAACAAAGAGAAACTTGTAATGGTCTCTGAAAAGGAATTGAGAAGTAATTCCTCTGATTCTGTTTTCTGGTGTTATATCTTTATTAAATATTCAGAAAAATTCACCAGTGAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lung</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Neutrophils</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>FPR2</Gene_Name>
    <Gene_Alias>FPRH1; FPRL1; LXA4R</Gene_Alias>
    <Gene_ID>2358</Gene_ID>
    <Genbank_ACCN>NM_001005738</Genbank_ACCN>
    <Protein_ACCN>NP_001005738</Protein_ACCN>
    <HGNC_ID>3827</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2358</Gene_URL>
    <UCSC_ID>uc002pxr.3</UCSC_ID>
    <EMBL_ID>ENSG00000171049</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Prion Disease</Disease_Name>
      <Disease_Detail>Prion Disease</Disease_Detail>
      <Disease_DB>PRN023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prion_disease?search=FPR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Amyloidosis</Disease_Name>
      <Disease_Detail>Amyloidosis</Disease_Detail>
      <Disease_DB>AMY004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/amyloidosis?search=FPR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bacterial Meningitis</Disease_Name>
      <Disease_Detail>Bacterial Meningitis</Disease_Detail>
      <Disease_DB>BCT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bacterial_meningitis?search=FPR2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of N-formyl peptide receptor 2</PDB_Title>
      <PDB_ID>ASD09250000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04080</Pathway_ID>
      <Pathway_Title>Neuroactive ligand-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05150</Pathway_ID>
      <Pathway_Title>Staphylococcus aureus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD09250001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>